<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-INR-17013311</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2017-11-09</date_registration>
      <primary_sponsor>Beijing Friendship Hospital affiliated to Capital Medical University </primary_sponsor>
      <public_title>Efficacy of microneeding plus mixed growth factors solutions derived from human mesenchymal stem cell for facial rejuvenation</public_title>
      <acronym />
      <scientific_title>Efficacy of microneeding plus mixed growth factors solutions derived from human mesenchymal stem cell for facial rejuvenation: a Randomized, Controlled, Blinded Split-Face Study</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2017-08-02</date_enrolment>
      <type_enrolment />
      <target_size>Two groups:25;</target_size>
      <recruitment_status>Completed</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=22453</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>面部年轻化</hc_freetext>
      <i_freetext>Two groups:microneeding alone or combined with mixed growth factors;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Zhuo Fenglin</firstname>
        <middlename />
        <lastname />
        <address>95 Yong'an Road, Xicheng District, Beijing, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15910895068</telephone>
        <email>zflsunny@hotmail.com</email>
        <affiliation>Beijing Friendship Hospital affiliated to Capital Medical University </affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Zhuo Fenglin</firstname>
        <middlename />
        <lastname />
        <address>95 Yong'an Road, Xicheng District, Beijing, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15910895068</telephone>
        <email>zflsunny@hotmail.com</email>
        <affiliation>Beijing Friendship Hospital affiliated to Capital Medical University </affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Aged 35-60 years male and female; Understand trial procedure and content and sign informed consent voluntarily;
2. No active skin disease on the face;
3. No facial filler such as hyaluronic acid or laser/light treatment;
4. No oral steroids,collagen powder/liquid,or topical hyaluronic acid used in the last 3 monthes;
5. No skin whitening products in the last 2 weeks.</inclusion_criteria>
      <agemin>35</agemin>
      <agemax>60</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. She is pregnant or in breast-feeding period;
2. To be allergic to trial medicine or its ingredient. No facial filler such as hyaluronic acid or laser/light treatment;
3. She/he had severe cardiovascular, cerebrovascular, renal, hepatic or hematopoietic disease;
4. She/he is taking part in the other clinical trial.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>skin pores;skin texture;skin winkle;UV spots;black brown spots;Erythema;skin hydration;skin transepidermal water loss;skin elasticity;skin melanin index;skin erythema index;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id>AMCTR-IOR-17000125</sec_id>
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>self-financing</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-07-28</approval_date>
        <contact_name>Li Yue</contact_name>
        <contact_address>Research department, Beijing Friendship Hospital affiliated to Capital Medical University </contact_address>
        <contact_phone>+86 13661202501</contact_phone>
        <contact_email>13661202501@163.com</contact_email>
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>